Product center
Marketed Products
Regulatory Review
Products
Development
Registration
Approved
Ipratropium bromide solution for inhalation 2ml:0.25mg
Ipratropium bromide solution for inhalation 2ml:0.5mg
Budesonide suspension for inhalation 2ml:0.5mg
Nebulized inhalation solution of terbutaline sulfate 1ml:2.5mg
Inhalation suspension of beclomethasone dipropionate 2ml:0.8mg
In Development
Products
Treatment field
Development
Registration
Approved
NLDP0111
COPD
HLDP0112
dispel phlegm (TCM)
LDP0202
COPD
HLDP0301
COPD
HLDP0303
eczema
HLDP0302
eczema
HLDP0503
antitumour
HLDP0504
antitumour
HLDP0505
antitumour
HLDP0506
analgesic
HLDP0507
antitumour
HLDP0508
antitumour
HLDP0509
antitumour
HLDP0510
antitumour
HLDP0603
psychiatric
HLDP0604
chronic inflammation
HLDP0607
psychiatric
HLDP0613
immune disease